Could Dogs Get Their Version Of Ozempic? Scientists Test "Ozempup" For Pet Obesity
The Birth Of 'Ozempup'
According to a Daily Mail report, biotech firm Vivani Medical has joined hands with Okava to work on a canine-friendly version of these medications. Informally called "Ozempup," the treatment aims to help overweight dogs manage their weight better.
How It Works
Unlike humans, who usually take weekly injections, dogs would receive the medication through a small implant called OKV-119, reported The Times of India. About the size of a microchip, the implant is placed under the skin and releases a steady dose for up to six months. Early trials in cats suggest the process is safe, and if dog trials go well, the product could be available by 2028.
Why Dogs Need Extra Help
Scientists say there is a need for such solutions because some dogs are genetically wired to overeat. Professor Alex German from the University of Liverpool explained, "There's a massive genetic component that drives the animal to be hungry all the time. Having an alternative approach, such as drugs, could be useful for clinicians to have another option."
For years, vets have relied on diet plans and exercise advice, but these approaches do not always work, especially for dogs with strong genetic tendencies. Owners often find themselves struggling with guilt and frustration when their pets do not lose weight.
Concerns And Caution
Still, experts urge caution. Dr. Helen Zomer from the University of Florida pointed out that more evidence is needed. "We don't have definitive answers on whether it would be a good solution or the potential consequences," she said.
Lessons From The Past
The discussion also brings back memories of Pfizer's attempt in 2007, when they introduced Slentrol, a drug meant to control appetite in dogs. It eventually had to be discontinued due to reported side effects like low energy and decreased happiness in pets.
What Owners Should Do For Now
For now, regular walks, balanced diets, and active play remain the safest ways to keep pets healthy. Whether "Ozempup" becomes a trusted option for vets and owners is something only time will reveal. But if successful, it could mark a big shift in how the pet obesity challenge is handled.
At the end of the day, the goal is the same: giving dogs longer, healthier, and happier lives.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
'It is a shortcut': Serena Williams opens up on GLP 1 weight loss journey and 31 pound drop before US Open
Serena Williams opens up on GLP 1 weight loss journey and 31 pound drop before US Open (Image via Getty) Serena Williams, the retired tennis legend, age 43, says she used a GLP-1 weight-loss medication to lose 31 pounds in eight months. She tried everything, running, biking, stair-climbing, even playing tennis professionally but couldn't reach a weight she felt was healthy. Now she feels lighter both physically and mentally. Serena Williams reveals weight loss journey with GLP-1 medication on Today show On August 21, 2025, on NBC's Today show, Serena Williams explained why she finally turned to GLP-1 drugs. She said, 'I literally tried everything. Running, walking, biking, stair-climber, you name it, I did it … Even now trying to play a professional sport, … I felt like, 'OK, I don't want to do this because it is a shortcut…' But it actually isn't.' She realized that after having her daughters, her body needed something more to reach a healthy weight. In interviews with People and others, Serena Williams added that she did lots of research first and consulted a doctor through Ro, the telehealth company she serves as an ambassador for. Around six months after giving birth to her second daughter, Adira, and after she stopped breastfeeding, she began weekly injections. She said the treatment complemented her healthy lifestyle, easing joint pain, boosting energy, and simply helping things work better. Also Read: 'Does anyone really care about her?': Andy Roddick delivers sharp message as Iga Swiatek gets disrespected following Cincinnati Open victory Serena Williams pushes back against stigma of weight loss drugs before US Open Serena Williams wants people to know using the medication is not a lazy shortcut. She said, 'If you're on GLP-1s too, don't let anybody tell you it's the 'easy way out.' You're not taking a shortcut, you're taking care of yourself.' She also said, 'I feel light physically and light mentally … I can just do more. I'm more active. My joints don't hurt as much.' Her timing was telling. This came just days before the U.S. Open, which begins August 24, 2025, an event she has previously won six times. Catch Rani Rampal's inspiring story on Game On, Episode 4. Watch Here!
Time of India
5 hours ago
- Time of India
Trending weight loss injections may bring more harm than good, warn medical experts
Lucknow: In a new trend, people with obesity are using injections originally prescribed for diabetics to lose weight. Doctors claim they receive 20–25 queries daily about the drugs, which studies show can cut body weight by 15–20%. However, experts caution that these injections are not a universal solution and pose serious health risks if misused. The commonly used drugs are GLP-1 receptor agonists (such as Semaglutide and Liraglutide) and Tirzepatide, a dual GLP-1 & GIP receptor agonist. While GLP-1 agonists are mainly for diabetics with obesity, Tirzepatide and Liraglutide may also be used in non-diabetic obese patients. However, the choice depends on clinical profile and cost, as treatment often lasts months or years. Prof Gaurav Pandey, faculty at the gastroenterology department, SGPGIMS, said, "We receive 8–10 queries a week, and around 10% of those become active users. These injections regulate blood sugar, curb appetite, and slow digestion, leading to gradual weight loss. But prolonged use may cause nausea, diarrhoea, acid reflux, pancreatitis, gallstones, or even paralysis of stomach muscles." "This is not a magic shot—it should only be used under the supervision of a bariatric or weight-loss surgeon," he said while insisting that oral drugs like SGTL2 may have some weight loss too. "The weight loss observed with SGLT2 inhibitors is generally less than what is typically seen with lifestyle interventions like diet and exercise, making people seek shortcuts that may be unsafe without medical guidance. There is no replacement for balanced eating habits, exercise, and a strong will to stay fit," Prof Pandey stressed. Dr Ankur Saxena, director of Robotic Minimal Access and Bariatric surgery at ApolloMedics Hospital, said 10–15% of young obese patients enquire about weight loss medicines. "These drugs are not for everyone. Extremely obese patients benefit more from bariatric surgery, with injections sometimes used as a bridge before surgery to improve safety," he explained. The injections can be prescribed to both diabetic and non-diabetic patients, though non-diabetics must monitor blood sugar to avoid hypoglycemia. "If symptoms occur, doctors advise consuming a sweet drink, checking sugar levels, and seeking immediate medical advice. Weight loss of 15–20% is possible with proper dosage, diet, and exercise, but experts emphasize that results often reverse if healthy lifestyle changes are not sustained," he said. Dr Sushil Gupta, principal director of endocrinology and diabetes at Max Super Speciality Hospital, said these injections are generally safe under endocrinologist supervision. "The choice of drug depends on factors such as diabetes status, BMI, fat distribution, extent of weight loss needed, and other illnesses. Side effects are usually manageable. Patients with high BMI who failed to lose weight, or those with conditions like sleep apnea, osteoarthritis, or heart disease linked to obesity often consider this therapy," he said. Gastroenterologist Punit Kumar, reports that rising obesity in cities like Lucknow—especially among children, youth, and women—is increasing the risk of serious health problems such as heart disease, Type II diabetes, and hypertension. They are also expensive, costing Rs 15,000-20,000 per month for long-term use, making them inaccessible for most people. Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and silver prices in your area.
NDTV
7 hours ago
- NDTV
Serena Williams Reveals She Lost 14 kg Using Weight-Loss Medication: "I Feel Great"
Serena Williams has opened up about her weight loss journey, revealing she lost 31 pounds (14 kg) with the help of a weight loss drug. The 23-time Grand Slam champion started using a GLP-1 medication after her second child, as part of a paid partnership with healthcare company Ro. Williams didn't specify which GLP-1 medication she's taking, but shared that she initially used it inconsistently before becoming fully committed to the treatment. She's been working with Ro to normalise the use of weight loss medications and break down stigmas surrounding them. According to Williams, the medication has not only helped her lose weight but also improved her overall health, with noticeable enhancements in her blood sugar levels and reduced joint pain. "I feel great. I feel really good and healthy. I feel light physically and light mentally," she told People. She also shared a video on Instagram, explaining the reasons behind her decision. "Taking care of yourself isn't a weakness, it's a power. I've never been about shortcuts, not in my career, and not in my health. I'm on a GLP-1 because it was the right tool to help me feel healthy," she wrote. View this post on Instagram A post shared by Serena Williams (@serenawilliams) The 43-year-old tennis star attributed the start of her weight struggles to 2017, following the birth of her daughter, Alexis Olympia, which was delivered via emergency C-section. She admitted that she was struggling to lose weight post-pregnancy, despite trying various methods such as intense workouts. She had also tried various diets, including vegan and vegetarian options, and a high-protein diet, as well as exercising regularly, often reaching 20,000 steps per day. "A misconception is that it's a shortcut. As an athlete and as someone that has done everything, I just couldn't get my weight to where I needed to be at a healthy place — and believe me, I don't take shortcuts," she told Today. "As a woman, you go through different cycles in your life. … No matter what I did — running, walking, I would walk for hours because they say that's good, I literally was playing a professional sport — and I could never go back to where I needed to be for my health. Then, after my second kid, it just got even harder. So, then I was like, OK, I have to try something different," she added. View this post on Instagram A post shared by Ro (@ Williams reported no side effects from the weight loss medication injections. She's now considering staying on the medication long-term, feeling like her body has found balance again. Serena Williams and her husband, Alexis Ohanian, Reddit's co-founder, have two daughters: 7-year-old Olympia and 2-year-old Adira. Notably, Ohanian is an investor in Ro, the healthcare company Williams partners with for her weight loss treatment. How do GLP-1 drugs work? GLP-1 drugs work by mimicking a natural hormone released after eating, leading to reduced appetite, feeling full faster, and slowed stomach emptying. These effects facilitate weight loss and also make the medications useful for treating diabetes by triggering insulin release. Typically, GLP-1 medications are prescribed for obesity or diabetes, often in conjunction with recommended lifestyle changes such as diet and exercise.
